The impact of cardiometabolic multimorbidity on cognitive function in older adults: a review
Huan Liu1, Junxiang Sun1, Ting Wang1
1Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Insights
Cardiometabolic multimorbidity (CMM) significantly accelerates cognitive decline and dementia in older adults. This review synthesizes CMM
Area of Science:
- Gerontology
- Neurology
- Cardiology
Background:
- Cardiometabolic multimorbidity (CMM) is a prevalent chronic condition.
- CMM is strongly linked to cognitive impairment and dementia progression.
- Current research on cognitive function in CMM is limited, especially in older adults.
Purpose of the Study:
- To review the impact of CMM on cognitive function in older adults.
- To synthesize current knowledge on the correlation between CMM and cognitive impairment.
- To explore underlying mechanisms, assessment tools, and risk factors for cognitive dysfunction in CMM.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of studies focusing on cardiometabolic diseases and cognitive function.
- Examination of data on older adults with multiple cardiometabolic conditions.
Main Results:
- CMM is a significant driver of cognitive dysfunction and dementia.
- Existing studies often overlook the complex interplay of multiple cardiometabolic diseases.
- Specific correlations, mechanisms, and risk factors require further investigation.
Conclusions:
- CMM poses a substantial threat to cognitive health in aging populations.
- There is a critical need for comprehensive understanding and management of CMM to prevent cognitive decline.
- Insights gained can inform screening and management strategies for high-risk individuals.
Abstract:
Cardiometabolic multimorbidity (CMM) represents the most prevalent and most detrimental chronic disease comorbidity pattern for cognitive impairment, directly accelerating cognitive dysfunction and dementia progression. However, existing research predominantly investigates cognitive function in patients with single diseases or specific binary comorbidities, leaving significant gaps in understanding the cognitive domain among older adults with CMM. This review focuses on the impact of CMM on cognitive function in the older adults synthesizing perspectives on their correlation, underlying mechanisms, assessment tools, and risk factors. It aims to provide insights for screening high-risk populations and formulating management strategies to delay the risk of cognitive dysfunction.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age
Coronary Artery Disease I: Introduction
Cardiomyopathy V: Interprofessional Care
Cognitive Development During Adulthood

